Yes, but the odds remain low. Letrozole raises the chance of conceiving twins to approximately 3 to 5 percent, compared to a natural twin rate of about 1 percent. The increase happens because letrozole can stimulate the ovaries to mature and release more than one egg in a single cycle. If two eggs are fertilized, the result is fraternal twins. For most women using letrozole for ovulation induction, a single healthy pregnancy remains the far more likely outcome. Getting pregnant with letrozole covers the basics of how it is used and what patients can expect.
How Does Letrozole Cause Multiple Eggs to Release?
Letrozole belongs to a class of drugs called aromatase inhibitors. It works by temporarily lowering estrogen levels, which signals the pituitary gland to release more follicle-stimulating hormone (FSH). That FSH surge encourages follicle development in the ovaries. In most cycles, one dominant follicle matures and releases a single egg. In some cycles, letrozole stimulates two or more follicles to reach maturity at the same time, leading to the release of multiple eggs.
What keeps the multiple rate relatively low is how letrozole works mechanically. Its estrogen-suppressing effect is temporary and self-limiting, so the body’s own feedback system still regulates follicle development. Letrozole tends to produce one or two mature follicles, not the larger numbers sometimes seen with injectable gonadotropins. The post on letrozole for women with ovulation problems explains the ovulation mechanism in more detail.
Twins from letrozole are almost always fraternal, meaning they come from two separate eggs fertilized by two separate sperm. Identical twins, which result from a single fertilized egg splitting, are not influenced by fertility medications.
How Does the Twin Rate for Letrozole Compare to Other Fertility Treatments?
Letrozole carries a lower multiple pregnancy rate than most other fertility medications. Comparing it to alternatives shows how that 3 to 5 percent range fits into the broader picture.
| Treatment | Approximate Twin Rate |
| Natural conception | ~1% |
| Letrozole | 3–5% |
| Clomiphene citrate (Clomid) | 5–10% |
| Injectable gonadotropins (IUI cycles) | 15–30% |
| IVF (single embryo transfer) | ~1–2% |
Letrozole consistently shows a lower multiple rate than Clomid in head-to-head studies. The large PPCOS II trial, which compared both medications in women with PCOS, confirmed this pattern. Injectable hormones carry a substantially higher multiple risk because they stimulate the ovaries more aggressively and are harder to titrate precisely. IVF with a single embryo transfer returns the twin rate close to natural levels, since only one embryo is placed. Infertility treatment options for both partners explains how these options fit into a broader fertility care pathway.
What Factors Affect Your Personal Odds of Twins on Letrozole?
That 3 to 5 percent figure describes an average across all patients using letrozole. Individual odds shift based on several variables.
Dose
Higher doses of letrozole stimulate more follicular activity. A standard starting dose is 2.5 mg per day for five days, but providers sometimes increase this to 5 mg or 7.5 mg in subsequent cycles if the response is insufficient. Higher doses increase the likelihood of multiple follicles maturing simultaneously, which raises the twin risk modestly.
Age and Ovarian Reserve
Women with a higher ovarian reserve, typically younger patients or those with PCOS, tend to respond more vigorously to ovarian stimulation. More follicles available for recruitment means a greater chance that multiple follicles will respond in the same cycle. The post on how fertility changes with age covers how ovarian reserve shifts over time and what that means for treatment planning.
PCOS
Women with polycystic ovary syndrome typically have a higher number of antral follicles available at any given time. Because letrozole stimulates follicular development, a larger starting pool can translate into a higher chance of multiple follicles maturing in one cycle. Letrozole is the preferred first-line medication for ovulation induction in women with PCOS. Its lower multiple rate compared to Clomid is one reason for that preference. The post on when to see an OB/GYN for PCOS explains how PCOS affects fertility and what evaluation looks like. For patients managing PCOS alongside treatment, improving fertility for PCOS patients with diet changes covers the lifestyle side of that picture.
Cycle Monitoring
Ultrasound monitoring during a letrozole cycle allows a provider to count mature follicles before triggering ovulation. If three or more mature follicles are present, a provider may recommend canceling the cycle or converting to IVF to avoid a high-order multiple pregnancy. Monitoring is one of the most effective tools available for managing multiple pregnancy risk. Tracking ovulation accurately for fertility covers what ovulation tracking looks like outside of a medicated cycle and how it fits into the broader fertility picture.
What Are the Risks of a Twin Pregnancy After Letrozole?
Twin pregnancies involve more active monitoring and care than singleton pregnancies, and understanding that picture upfront helps patients plan well.
Preterm delivery is the most common pregnancy complication in twins. About half of twin pregnancies deliver before 37 weeks, compared to roughly 10 percent of singleton pregnancies. Newborn care teams are well equipped to support preterm infants, though a NICU stay is possible.
Maternal considerations in twin pregnancies include gestational diabetes, preeclampsia and anemia, which occur at elevated rates compared to singleton pregnancies. Cesarean delivery is also more common, and postpartum recovery can be more demanding.
These are not reasons to avoid letrozole. They are part of the informed conversation any provider should have before starting an ovulation induction cycle. For patients who conceive twins, specialized monitoring throughout the pregnancy becomes part of the care plan. What weekly ultrasounds should look like for twins and multiple gestations describes what that surveillance typically involves. Roswell Ob/Gyn, LLC also provides high-risk pregnancy care for patients who need specialized monitoring throughout a multiple gestation.
What Are the Other Side Effects of Letrozole Beyond Multiple Pregnancies?
Hot flashes are the most commonly reported side effect, occurring in some studies in up to 25 percent of patients. They are typically mild and resolve after the medication course ends. Headache, fatigue and mild pelvic discomfort during the stimulation phase are also reported. Nausea occurs in a smaller percentage of patients.
Ovarian hyperstimulation syndrome (OHSS) is significantly less common with letrozole than with injectable gonadotropins. Letrozole’s self-limiting mechanism makes severe OHSS rare. Mild bloating and pelvic pressure around ovulation time are more typical.
Letrozole is now considered safe for ovulation induction based on current evidence. Early case reports raised a question about fetal cardiac outcomes, but subsequent large-scale studies did not confirm that association. Providers today use letrozole routinely for ovulation induction with confidence in the safety data.
Who Is Letrozole Typically Prescribed For?
Letrozole is primarily used for ovulation induction in women who do not ovulate regularly on their own. This includes women with PCOS, unexplained infertility and irregular cycles. It is also used as part of an IUI cycle to improve timing and egg production.
It is generally not prescribed for women with diminished ovarian reserve, premature ovarian insufficiency or blocked fallopian tubes. Ovulation induction does not address the underlying issue in those cases. An infertility workup is the standard starting point for identifying what is actually preventing conception before a treatment path is chosen. What is taking so long when you wanted to be pregnant yesterday covers the emotional and clinical side of navigating fertility delays and when a workup makes sense.
Age, cycle history, prior treatment response and partner factors all shape the right treatment path. A provider can review these factors and determine the best starting point based on the full picture.
Starting Your Fertility Conversation
Letrozole is an effective and well-studied option for ovulation induction, with a multiple pregnancy rate that stays meaningfully lower than Clomid or injectables. For most patients, a singleton pregnancy is the outcome. Understanding the twin risk, how monitoring works and what factors shape your individual odds prepares you for a productive conversation with your provider.
For patients who do conceive, what to expect at your first prenatal care visit is a useful next read. At Roswell Ob/Gyn, LLC, infertility evaluation and treatment are available across all four locations in Alpharetta, Atlanta, Canton and Cumming. Contact Roswell Ob/Gyn, LLC to schedule a fertility consultation and find the treatment path that fits your situation.
Frequently Asked Questions
Does letrozole increase the chance of identical twins?
No. Letrozole works by stimulating the ovaries to release eggs. Identical twinning happens when one fertilized egg splits spontaneously, a process that occurs independently of how many eggs were released. Letrozole does not influence that process.
How many eggs does letrozole typically release?
In most cycles, letrozole results in the release of one egg. In approximately 3 to 5 percent of cycles, two or more eggs are released, which is what creates the elevated twin risk. Ultrasound monitoring during the stimulation phase can confirm how many follicles are maturing before ovulation occurs.
Can you request monitoring to reduce the risk of twins on letrozole?
Yes, and it is standard practice at many fertility-focused OB/GYN offices. Transvaginal ultrasound around day 10 to 12 of the cycle can show how many mature follicles are present. If multiple follicles are ready to ovulate, your provider can discuss your options, including cycle cancellation, before proceeding. Monitoring does not eliminate the risk but gives both patient and provider the information needed to make an informed decision.
Is a twin pregnancy after letrozole considered high risk?
Yes. All twin pregnancies are classified as high risk. This means more frequent prenatal visits, additional ultrasounds and closer monitoring throughout the pregnancy. The role of an OB/GYN in monitoring and managing high-risk pregnancies describes what that level of care involves and what patients can expect from a high-risk prenatal program.
What are the disadvantages of taking letrozole for fertility?
The main disadvantages are the small but real risk of a multiple pregnancy and mild side effects during the treatment window. It also does not address all causes of infertility. Letrozole is most effective when the primary issue is ovulatory dysfunction. In cases involving tubal damage, sperm factors or poor ovarian reserve, other treatment pathways are more appropriate. A thorough infertility evaluation before starting any medication ensures the treatment matches the underlying cause.
Does letrozole improve pregnancy rates compared to no treatment?
For women with PCOS who are not ovulating, yes, substantially. Letrozole restores ovulation in the majority of cycles in which it is used and produces higher cumulative pregnancy rates than Clomid in several large trials. For women who ovulate on their own, the benefit is more modest and depends on individual circumstances.
